Company / Interest Expense
IQVIA Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$729.0M
FY2025
5-year range
$416.0M / $729.0M
FY2021-FY2025
Trend
+8.8%
vs FY2024
Sector context
#4 of 44
Health Care
What the data says
Among 44 Health Care companies, IQVIA is in the bottom 9% for interest expense. Interest Expense has fluctuated over the past 10 years, ranging from $144M in FY2018 to $729M in FY2025.
Based on SEC 10-K filings.
$729M in FY2025 with a 5-year CAGR of +12.0%. Top quartile in the Health Care sector.
Increased from $672M to $729M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +20.6%
- 5-Year CAGR
- +12.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 44This company $729.0M Sector average $316.9M
▼
+130.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +12.0%, indicating consistent growth.
- In FY2025, interest expense increased 8.8% year-over-year.
- Ranks #4 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $729.0M | +8.8% |
| FY2024 | $670.0M | -0.3% |
| FY2023 | $672.0M | +61.5% |
| FY2022 | $416.0M | -6.9% |
| FY2021 | $447.0M | +8.0% |
| FY2020 | $414.0M | +19.7% |
| FY2019 | $346.0M | +140.3% |
| FY2018 | $144.0M | -58.4% |
| FY2017 | $346.0M | +140.3% |
| FY2016 | $144.0M | +42.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026